ArticlePharmacoEconomics2001

Cost effectiveness of ramipril in patients with non-diabetic nephropathy and hypertension: economic evaluation of Ramipril Efficacy in Nephropathy (REIN) Study for Germany from the perspective of statutory health insurance.

P K Schädlich et al.PubMed ↗Publisher ↗

No numbers read from the abstract.